Innoviva Strategic Opportunities LLC, Director, 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 3,614,792 shares at $5.00 ($18.1M) on 2022-02-09, disclosed to the SEC on 2022-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ETTX | BUY | 2021-06-11 | $12.5M | — | Filing → |
| ARMP | BUY | 2021-01-28 | $6.1M | — | Filing → |